SRC and thyroid gland carcinoma: Another study also found that dasatinib could inhibit the growth of cancer cells, induce apoptosis and cell cycle arrest, and prevent tumor growth and metastasis, which all suggest that Src pathway is very important for the growth and metastasis of thyroid cancer, and Src inhibitors could effectively block thyroid cancer growth and metastasis [10].